View of Efficacy of Upadacitinib vs Dupilumab Treatment for Moderate‑to‑Severe Atopic Dermatitis: Analysis of Time Spent in Response State From the Level Up Study

Return to Article Details Efficacy of Upadacitinib vs Dupilumab Treatment for Moderate‑to‑Severe Atopic Dermatitis: Analysis of Time Spent in Response State From the Level Up Study Download Download PDF